Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseasesMichelle M. Clark, Stephen F. Kingsmore, Zornitza Stark et al.|npj Genomic Medicine|2018Cited by 637
A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disordersZornitza Stark, Susan M. White, Tiong Yang Tan et al.|Genetics in Medicine|2016Cited by 411
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic ConditionsTiong Yang Tan, Susan M. White, Oliver James Dillon et al.|JAMA Pediatrics|2017Cited by 327
Genome Sequencing for Diagnosing Rare DiseasesMonica H. Wojcik, Daniel G. MacArthur, Gabrielle Lemire et al.|New England Journal of Medicine|2024Cited by 186
Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectivenessZornitza Stark, Susan M. White, Deborah Schofield et al.|Genetics in Medicine|2018Cited by 174